Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

RVMDRVMD

Showing 8 of 26 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in REVOLUTION MEDICINES INC

Yes. Price T Rowe Associates holds 2,390,303 shares of RVMD (Revolution Medicines), worth $447.7M, as of its Q2 2026 13F filing. It reduced the position by 841,910 shares (-26.1%) from Q1 2026. Price T Rowe Associates has held RVMD since Q4 2020, across 23 quarterly 13F filings.

Current Value

$447.7M

Current Shares

2.4M

Total Value Change

+$206.7M

Total Shares Change

-2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.4M
-26.1%
$447.7M0.0%$187.28
0
2026-Q1
Decreased
3.2M
-5.1%
$314.3M0.0%$100.49
0
2025-Q4
Decreased
3.4M
-12.1%
$271.2M0.0%$79.67
0
2025-Q3
Decreased
3.9M
-17.6%
$180.9M0.0%$46.07
0
2025-Q2
Decreased
4.7M
-16.0%
$173M0.0%$36.91
0
2025-Q1
Decreased
5.6M
-4.5%
$198M0.0%$37.35
0
2024-Q4
Increased
5.9M
+10.4%
$256.6M0.0%$43.17
34
2024-Q3
Increased
5.3M
+1.9%
$241M0.0%$44.17
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used